EN
instrument_fundamentals
| date | Close | change | Change (%) | instr__open | High | Low |
|---|
News
In 2024, pandemic breakthroughs were for better and for worse | BioWorld
Gilead Sciences, Inc. - Insider Monkey
Gilead Sciences invests $20.1 million in Assembly Biosciences By Investing.com
Gilead Sciences (GILD) Made Big Announcements in Q3
Gilead Sciences, Inc. (NASDAQ:GILD) Position Raised by Principal Financial Group Inc.
Gilead Sciences Inc (GILD) to Present at J.P. Morgan Healthcare Conference
Gilead Sciences to Present at Upcoming Investor Conference By Investing.com
Company Website: https://www.gilead.com/ FOSTER CITY, Cali
Gilead Sciences to Present at Upcoming Investor Conference | Morningstar
Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? - December 20, 2024 - Zacks.com
Is Atossa Genetics (ATOS) Stock Outpacing Its Medical Peers This Year? - December 20, 2024 - Zacks.com
Sacituzumab Govitecan Does Not Significantly Improve OS in Pretreated Urothelial Carcinoma
Assembly Bio Receives Total $30.1 Mln As Equity Investment, Funding From Gilead, Stock Up
Assembly Biosciences Shares Rise 19% After Gilead Investment, Funding | Morningstar
Gilead Sciences acquires $1.83 million in Xilio Therapeutics stock By Investing.com
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs | The Manila Times
Xilio Therapeutics Enters into Additional Private Placement with Gilead; Issues Securities at $25 Million Aggregate Investment
Announces preliminary Phase 1 data for XTX301, a tumor-activ
Assembly Biosciences Announces $30.1 Million Equity Investment and Accelerated Funding from Gilead to Advance Clinical Development Programs By Investing.com
USFDA gives nod to Lupin’s generic formulation to treat HIV infection
Lupin gets USFDA approval for generic HIV tablets | India Infoline
Gilead Sciences (GILD) Gains As Market Dips: What You Should Know - December 19, 2024 - Zacks.com
Lupin Limited: Lupin’s HIV tablets get FDA nod, Pharma News, ETPharma
Andrew D. Dickinson Sells 8,500 Shares of Gilead Sciences, Inc. (NASDAQ:GILD) Stock
Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains - December 18, 2024 - Zacks.com
5 High Earnings Yield Value Picks to Buy for 2025 - December 18, 2024 - Zacks.com
GILD's Trodelvy Gets Second Breakthrough Therapy Tag for Lung Cancer - December 18, 2024 - Zacks.com
Gilead and Terray Therapeutics collaborate on drug discovery | BioWorld
New HIV prevention drug could reach poorest countries by 2025, says health official | The Star
Gilead Sciences CFO sells $781,660 in stock By Investing.com
FDA grants breakthrough status to Gilead's lung cancer drug By Investing.com
Gilead Sciences, Terray Therapeutics Set AI-Powered Research Collaboration | Morningstar
FDA Grants Breakthrough Therapy Status To Gilead's Trodelvy For Treatment Of Small Cell Lung Cancer
Gilead Inks Strategic Collaboration With Terray Therapeutics To Develop Small Molecule Therapies
B. Riley Wealth Advisors Inc. Sells 15,668 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
New HIV prevention drug could reach poorest countries by 2025, says health official By Reuters
Bernstein remains bullish on Gilead stock, sees leadership strengthening future growth By Investing.com
Gilead partners with Terray for AI-driven drug discovery By Investing.com
Gilead Sciences, Inc. (NASDAQ:GILD) Sees Large Increase in Short Interest
Gilead (GILD) Upgraded to Buy: Here's Why - December 16, 2024 - Zacks.com
GILD Obtains Positive CHMP Opinion for Liver Disease Drug - December 16, 2024 - Zacks.com
Roche Gets Approval for Vabysmo PFS in EU for Three Retinal Diseases - December 16, 2024 - Zacks.com
Gilead Sciences' SWOT analysis: lenacapavir success fuels HIV stock growth By Investing.com
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Franklin Resources Inc.
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Synovus Financial Corp
Wilmington Savings Fund Society FSB Has $1.56 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Moderate Buy" from Brokerages
DGS Capital Management LLC Sells 1,492 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
DGS Capital Management LLC Has $300,000 Position in Gilead Sciences, Inc. (NASDAQ:GILD)
50,000 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Bought by Exome Asset Management LLC
2,495 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Pine Valley Investments Ltd Liability Co
2,883 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Brass Tax Wealth Management Inc.
Retirement Systems of Alabama Cuts Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by American Trust
Tri Ri Asset Management Corp Buys Shares of 40,314 Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Purchased by Tidal Investments LLC
Gilead Gets Key European Backing for Liver-Disease Treatment | Morningstar
Gilead Sciences, Inc. (NASDAQ:GILD) Stock Position Lifted by Sanctuary Advisors LLC
Gilead Sciences Says Seladelpar Gets Positive CHMP Opinion For Primary Biliary Cholangitis
Leerink Partnrs Lifts Earnings Estimates for Gilead Sciences
Gilead’s Seladelpar Receives Positive CHMP Opinion for Primary Biliary Cholangitis | Morningstar
Gilead Sciences, Inc. (NASDAQ:GILD) Position Trimmed by TCW Group Inc.
Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Teachers Retirement System of The State of Kentucky
XTX Topco Ltd Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences: Gilead appoints Sanofi official Dietmar Berger as next chief medical officer, ETPharma
Seladelpar wins CHMP endorsement for rare liver disease By Investing.com
Gilead Sciences (GILD) Stock Moves -0.57%: What You Should Know - December 13, 2024 - Zacks.com
Stock Traders Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD)
SkyView Investment Advisors LLC Purchases 435 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Blankinship & Foster LLC Takes $1.01 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead appoints Sanofi official Dietmar Berger as next chief medical officer By Reuters
Arvest Bank Trust Division Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Te Ahumairangi Investment Management Ltd Sells 9,587 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)
Zacks Research Forecasts Higher Earnings for Gilead Sciences
Tri Ri Asset Management Corp Takes Position in Gilead Sciences, Inc. (NASDAQ:GILD)
TD Private Client Wealth LLC Increases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Toronto Dominion Bank Trims Stake in Gilead Sciences, Inc. (NASDAQ:GILD)
Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It - December 12, 2024 - Zacks.com
Is Gilead Sciences (GILD) Stock Undervalued Right Now? - December 12, 2024 - Zacks.com
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal - December 12, 2024 - Zacks.com
Gilead Sciences’ (GILD) “Neutral” Rating Reiterated at Cantor Fitzgerald
Macy's gives update on employee who hid $151M
Gilead Sciences, Inc. (GILD) To Go Ex-Dividend on December 13th
Gilead stock outlook hinges on Lenacapavir's PrEP launch and untapped patient expansion, says DB By Investing.com
TT International Asset Management LTD Invests $1.26 Million in Gilead Sciences, Inc. (NASDAQ:GILD)
LRI Investments LLC Boosts Position in Gilead Sciences, Inc. (NASDAQ:GILD)
M&T Bank Corp Has $16.18 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
This pharma stock could easily gain 20% next year, Jefferies says By Investing.com
CRDF Stock Soars on Robust Efficacy Data From Colorectal Cancer Study - December 11, 2024 - Zacks.com
QURE Soars on FDA Alignment for Speedy Approval of Huntington's Drug - December 11, 2024 - Zacks.com
Vestcor Inc Reduces Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
Oppenheimer Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock
Gilead Sciences (NASDAQ:GILD) Given "Buy" Rating at Bank of America
15,203 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Purchased by Brophy Wealth Management LLC
